Medexus Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Feb 24 | BuyUS$3,988 | Benoit Gravel | Individual | 3,200 | US$1.25 | |
30 Jun 23 | BuyUS$98,843 | Stephen Nelson | Individual | 93,800 | US$1.05 | |
29 Jun 23 | BuyUS$4,791 | Kenneth d'Entremont | Individual | 3,800 | US$1.26 | |
23 Jun 23 | BuyUS$7,602 | Michael Mueller | Individual | 7,000 | US$1.09 | |
23 Jun 23 | BuyUS$16,127 | Kenneth d'Entremont | Individual | 15,000 | US$1.08 | |
23 Jun 23 | BuyUS$5,304 | Marcel Konrad | Individual | 5,100 | US$1.04 |
Insider Trading Volume
Insider Buying: MEDX.F insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Hedge Funds | 1,536,000 | 6.28% |
Institutions | 1,607,546 | 6.57% |
Individual Insiders | 2,330,996 | 9.53% |
General Public | 18,984,131 | 77.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,536,000 | US$2.0m | -35.2% | 0.05% | |||
1,461,869 | US$1.9m | 0% | no data | |||
1,038,716 | US$1.4m | 0% | 39.07% | |||
547,079 | US$715.8k | 0% | no data | |||
432,063 | US$565.3k | 0% | 0.92% | |||
135,100 | US$176.8k | 0% | 0.09% | |||
89,870 | US$117.6k | 0% | no data | |||
80,021 | US$104.7k | 0% | no data | |||
56,358 | US$73.7k | 6.02% | no data | |||
28,800 | US$37.7k | 0% | no data | |||
20,634 | US$27.0k | 0% | no data | |||
19,847 | US$26.0k | 0% | no data | |||
13,259 | US$17.3k | 0% | no data | |||
13,259 | US$17.3k | 0% | no data | |||
1,667 | US$2.2k | 0% | 100.0% |